NCT00075504View on ClinicalTrials.gov

Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Stage II Gallbladder CancerStage IIIA Gallbladder CancerStage IIIB Gallbladder CancerStage IVA Gallbladder CancerStage IVB Gallbladder Cancer
Interventions
DRUG

triapine

Given IV

DRUG

gemcitabine

Given IV

Trial Locations (1)

10467-2490

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00075504 - Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer | Biotech Hunter | Biotech Hunter